Alertgy
Alertgy is a biotech company developing a non-invasive continuous glucose monitoring device called Alertgy NICGM, a wristband that works with a smartphone app to measure blood sugar levels painlessly without drawing blood. The device aims to provide real-time, on-demand glucose readings, track blood sugar trends, and send alerts to users and caregivers if levels become dangerously high or low. The company is currently in clinical trials and plans to launch the product by 2023, targeting diabetics and healthcare providers. Alertgy's technology is differentiated by its non-invasive sensor technology, cost-effectiveness, and user-friendly design, positioning it as a disruptive innovation in diabetes management.
Alertgy
Alertgy is a biotech company developing a non-invasive continuous glucose monitoring device called Alertgy NICGM, a wristband that works with a smartphone app to measure blood sugar levels painlessly without drawing blood. The device aims to provide real-time, on-demand glucose readings, track blood sugar trends, and send alerts to users and caregivers if levels become dangerously high or low. The company is currently in clinical trials and plans to launch the product by 2023, targeting diabetics and healthcare providers. Alertgy's technology is differentiated by its non-invasive sensor technology, cost-effectiveness, and user-friendly design, positioning it as a disruptive innovation in diabetes management.